arrow_back Back Filing freshness 20-F Q4 FY2026 SEC EDGAR
download Export Data

Haoxi Health Technology Ltd

HAO
$1.85 ▼ -0.10 (-5.13%) at close
Industrials ·Services-Advertising Agencies ·USServices-Advertising Agencies
6 Visible periods
5 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

Haoxi Health Technology Ltd faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC —
FCF / Share —
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity 0.07
info Valuation on last close. End-of-day price, Nov 5, 2026.

6-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Long-Term Debt Long-term obligations
$307.32K
↑ +1.9% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
8
Returns ↓
14
Financial Health ↓
46
Cash Quality
29

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 6 years · 6 quarters